Ross is a partner in the Corporate Technology & Life Sciences team, based in our Cambridge office.

Ross is a lead partner within the firm's Tier 1-ranked Biotechnology practice in Cambridge. His practice involves helping life sciences and technology companies as they progress through their life cycle in all aspects of their growth, capital raising and international expansion. As a sector specialist, Ross focuses on biotech, medical devices and diagnostics within Life Sciences, and with the Tech sector supports companies operating in the capital intensive deep tech space, including quantum computing, artificial intelligence, advanced materials, as well as web3.

Ross has extensive experience of a variety of venture and growth financing, public capital raisings, mergers and acquisitions and general corporate advice. Ross was based out of San Francisco, CA in 2018 – 19 and as a result, he has a particular expertise in transactions with a transatlantic component.

Afficher le CV complet Masquer le CV complet

Actualités et publications récentes

Sciences de la vie et Santé

Word on the street at the J.P. Morgan Healthcare Conference 2023

1 février 2023

par plusieurs auteurs

Cliquer ici pour en savoir plus

Ross McNaughton recognised in The Lawyer's 2023 Hot 100

23 janvier 2023

par Ross McNaughton

Cliquer ici pour en savoir plus

Supporting regional talent growth with our new Cambridge training contracts

30 septembre 2022

par Ross McNaughton

Cliquer ici pour en savoir plus
Fusions et acquisitions d’entreprises et marchés financiers internationaux

Advising Panmure Gordon on £6 million placing for biopharmaceutical group Arecor Therapeutics

7 septembre 2022

par Ross McNaughton

Cliquer ici pour en savoir plus